Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 174

    1.

    Non-HDL cholesterol and apolipoprotein B in the dyslipidemic classification of type 2 diabetic patients.

    Wägner AM, Pérez A, Zapico E, Ordóñez-Llanos J.

    Diabetes Care. 2003 Jul;26(7):2048-51.PMID: 12832311 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.

    Wägner AM, Pérez A, Calvo F, Bonet R, Castellví A, Ordóñez J.

    Diabetes Care. 1999 May;22(5):812-7.PMID: 10332687 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Hypertriglyceridemic hyperapoB in type 2 diabetes.

    Sniderman AD, Lamarche B, Tilley J, Seccombe D, Frohlich J.

    Diabetes Care. 2002 Mar;25(3):579-82.PMID: 11874951 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes.

    Wägner AM, Jorba O, Rigla M, Alonso E, Ordóñez-Llanos J, Pérez A.

    Acta Diabetol. 2002 Dec;39(4):215-20.PMID: 12486496 [PubMed - indexed for MEDLINE]Related articles

    5.

    A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia.

    Al-Bahrani AI, Bakhiet CS, Bayoumi RA, Al-Yahyaee SA.

    Diabetes Res Clin Pract. 2005 Jul;69(1):44-51.PMID: 15904989 [PubMed - indexed for MEDLINE]Related articles

    6.

    Postprandial lipidemia is normal in non-obese type 2 diabetic patients with relatively preserved insulin secretion.

    Wägner AM, Ordóñez-Llanos J, Arcelus R, Bonet R, Jorba O, Sánchez-Quesada JL, Alonso E, Julve J, Pérez A.

    Metabolism. 2003 Aug;52(8):1038-42.PMID: 12898470 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lipid abnormalities associated with urinary albumin excretion rate in Taiwanese type 2 diabetic patients.

    Tseng CH.

    Kidney Int. 2005 Apr;67(4):1547-53.PMID: 15780110 [PubMed - indexed for MEDLINE]Related articles

    9.

    Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).

    Charlton-Menys V, Betteridge DJ, Colhoun H, Fuller J, France M, Hitman GA, Livingstone SJ, Neil HA, Newman CB, Szarek M, DeMicco DA, Durrington PN.

    Clin Chem. 2009 Mar;55(3):473-80. Epub 2009 Jan 15.PMID: 19147732 [PubMed - indexed for MEDLINE]Related articles

    10.

    Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites.

    Martin SS, Qasim AN, Mehta NN, Wolfe M, Terembula K, Schwartz S, Iqbal N, Schutta M, Bagheri R, Reilly MP.

    Diabetes. 2009 Aug;58(8):1887-92. Epub 2009 Jun 2.PMID: 19491209 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Quantitative effect of glycaemic improvement on the components of diabetic dyslipidaemia: a longitudinal study.

    Wägner AM, Ordóñez-Llanos J, Caixàs A, Bonet R, de Leiva A, Pérez A.

    Diabetes Res Clin Pract. 2005 Apr;68(1):81-3.PMID: 15811569 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.

    O'Neal DN, Lewicki J, Ansari MZ, Matthews PG, Best JD.

    Atherosclerosis. 1998 Jan;136(1):1-8.PMID: 9544725 [PubMed - indexed for MEDLINE]Related articles

    13.

    Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B: relationships among the different measurements.

    Franzini C, Valente C, Luraschi P.

    Scand J Clin Lab Invest. 2004;64(8):703-7.PMID: 15719888 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of improving glycemic control on low-density lipoprotein particle size in type 2 diabetes.

    Wägner AM, Jorba O, Rigla M, Bonet R, de Leiva A, Ordóñez-Llanos J, Pérez A.

    Metabolism. 2003 Dec;52(12):1576-8.PMID: 14669158 [PubMed - indexed for MEDLINE]Related articles

    15.

    Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.

    Jiang R, Schulze MB, Li T, Rifai N, Stampfer MJ, Rimm EB, Hu FB.

    Diabetes Care. 2004 Aug;27(8):1991-7.PMID: 15277429 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study.

    Bruno G, Merletti F, Biggeri A, Bargero G, Prina-Cerai S, Pagano G, Cavallo-Perin P.

    Diabetologia. 2006 May;49(5):937-44. Epub 2006 Mar 9.PMID: 16525840 [PubMed - indexed for MEDLINE]Related articles

    17.

    Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

    Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB.

    Circulation. 2005 Nov 29;112(22):3375-83.PMID: 16316964 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet.

    Fisher WR, Zech LA, Stacpoole PW.

    J Lipid Res. 1998 Feb;39(2):388-401.PMID: 9507999 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.

    Hernández C, Chacón P, García-Pascual L, Simó R.

    Diabetes Care. 2001 Feb;24(2):350-5.PMID: 11213891 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).

    Charlton-Menys V, Betteridge DJ, Colhoun H, Fuller J, France M, Hitman GA, Livingstone SJ, Neil HA, Newman CB, Szarek M, DeMicco DA, Durrington PN.

    Diabetologia. 2009 Feb;52(2):218-25. Epub 2008 Oct 30. Erratum in: Diabetologia. 2009 Mar;52(3):556. PMID: 18972097 [PubMed - indexed for MEDLINE]Related articles